Proud Member of ACNP
About EMA Wellness
We purpose built our clinical trials platform to provide critical trial functions, but with the benefits of providing them more efficiently in one singular environment.
The EMA platform was initially architected to collect, validate and report on ecological momentary assessment (EMA), audio/video and sensor derived data. These are exponentially larger, more complex data which require highly sophisticated and robust models to both clean and structure than traditional eCOA’s or structured outcomes. Consequently, our efforts to integrate the smaller and better structured eCOA data into our platform four years ago was seamless.
The benefits of having multimodal data collected and structured in one purpose built canonical environment are many, mostly around data speed, quality and cost. For instance, data in our platform is readily extractable, and provides instant insights as well as (actual) real time, rules-based notices which inform decisions to dive deeper.
Our scientific founders have worked with pharma partners to define and configure rules for notifications, flags and alerts for each study. These trigger clinical reviews or other adjudication actions which immediately assess anomalies or signals and serve to improve patient selection and overall data quality. The scheduling logistics and findings for any remediation are managed inside of our platform, including full audit trails and regulatory ready reports.
This integration of data and features precludes the need for extraneous third-party data analytics platforms, for example, or other traditional eCOA, ePRO or sensor providers. We also manage rater training, central ratings, rater surveillance, scale management and other services to make it even easier to work with us.
This integration of data, analytics and functionality makes EMA Wellness’ singular technology platform unique in clinical trials today.
Building world class companies: Leadership Team
COLIN BOWER
Executive Chairman
CO-FOUNDER
- 3 successful digital health exits in last 10 years
Alison Silva
Head of Clinical Operations
Co-Founder Synologic
- Director Jupiter Therapeutics
- COO SLA Pharma, VP Marina Bio
Stephen Saber
Chief Operating Officer
CO-FOUNDER
- 4 successful IT exits in last 10 years
Dan DeBonis
Chief Product Officer
CO-FOUNDER CONCORDANT RATER SYSTEMS
- Principal Endpoint Solutions Signant Health
- Co-Founder Concordant Rater Systems
Building world class companies: Scientific Founders
DR. CHARLES NEMEROFF
- Chair and professor with the Department of Psychiatry and Behavioral Sciences Dell Medical School, University of Texas
- Co-director of the Center for Psychedelic Research and Therapy
DR. PHILIP HARVEY
- Professor of Psychiatry and Behavioral Sciences University of Miami Miller School of Medicine
- Leading KOL in schizophrenia